UBS Maintains Neutral on Humana, Raises Price Target to $262

Benzinga Newsdesk www.benzinga.com Positive 60.1%

Neg 0% Neu 0% Pos 60.1%

UBS analyst A.J. Rice maintains Humana (NYSE:HUM) with a Neutral and raises the price target from $195 to $262.

Comments

No comments yet. Be the first!